APA (7th ed.) Citation

Ngiam, J. N., Loy, E. X., Koh, M. C. Y., Chiew, C. J., Li, R. J., Lim, S. C., . . . Wee, L. E. (2026). Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Infectious Diseases & Therapy, 15(7), 1955. https://doi.org/10.1007/s40121-026-01362-z

Chicago Style (17th ed.) Citation

Ngiam, Jinghao Nicholas, et al. "Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study." Infectious Diseases & Therapy 15, no. 7 (2026): 1955. https://doi.org/10.1007/s40121-026-01362-z.

MLA (9th ed.) Citation

Ngiam, Jinghao Nicholas, et al. "Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study." Infectious Diseases & Therapy, vol. 15, no. 7, 2026, p. 1955, https://doi.org/10.1007/s40121-026-01362-z.